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Aging is a strong independent risk factor for the developmentofcardiovascular
disease . The association of other risk factors, such as cigarette smoking and
hyperlipidemia, with cardiovascular disease decreases with age (1) . Investigations
in both humans and other species suggest that the proliferation of vascular
smooth muscle cells (SMCs)' is an early pathological feature of arteriosclerosis
(2). In animal models of arteriosclerosis, aging accelerates injury-induced SMC
proliferation . Stemerman et al . (3) observed more rapid, more pronounced, and
more prolonged incorporation of tritiated thymidine by arterial cells in old
compared with young rat aortas after balloon catheter-induced injury . By
performing aortic transplants between old and young rats, Hariri et al . (4)
demonstrated that exaggerated intimal plaque formation in aortas from old rats
was a characteristic of the age of the artery, not theageof the animal . Combined,
these studies suggested that the increased susceptibility of aged arteries to
arteriosclerosis is related to an exaggerated proliferative response by arterial
cells after injury .
We have examined the proliferative capacity of SMCs isolated from aortas of
old and young rats to provide insight into the increased susceptibility to arterio-
sclerosis with aging. We now report evidence that aging is associated with
dysregulation of the proliferative responses of SMCs from old aortas . This
dysregulation is characterized by increased proliferation of old SMCs both in the
presence and absence of serum, and is associated with enhanced growth-factor
activity and decreased growth-inhibitory activity of the old SMCs .
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Materials and Methods
Reagents.
￿
RPM11640and Medium 199, both containing 25mM Hepes, FCS, newborn
calf serum (NCS), plasma-derived serum (PDS), trypsin-EDTA solution, and gentamycin
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'Abbreviations used in this paper:
￿
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sulfate were purchased from Flow Laboratories, Inc. (McLean, VA). Hepes-buffered
saline (HBS) consists of 0.15 M NaCl, 0 .025 M Hepes, 0.040 M KCI, pH 7 .4. Serum-free
media (HL-1, Ventrex Labs, Portland, ME) contained no platelet-derived growth factor
(PDGF), but contained progression factors including insulin, transferrin, and selenium.
All sera used were tested for capacity to support growth of young adult SMCs. Media
containing 2% PDS did not permit proliferation of young SMCs, but allowed maintenance
of a stable cell number. PDGF was purchased from Bethesda Research Laboratories
(Gaithersburg, MD) or from Collaborative Research (Lexington, MA); both products
were reported as >97% pure by SDS-PAGE and NH2-terminus sequencing. Antibody to
PDGF (rabbit anti-human PDGF) was kindly provided by Drs. G. Pierce and T. Deuel
(Washington University, St. Louis, MO). 120 U/mg Sodium heparin (Gibco, Grand Island,
NY) was prepared as a stock solution of 1 mg/ml in media and sterilized by passage
through a 0 .22-Am filter (Millex GS, Millipore Co., Bedford, MA). [sH]TdR (2 Ci/mmol)
was purchased from New England Nuclear (Boston, MA).
Isolation of Rat SMCs.
￿
Old (>19 mo) and young (<3 mo) male Fischer 344 rats were
acquired from the NIA Harlan-inbred line. Rat aortic SMCs were isolated from aortas
by modifications of published methods (5). Immediately after death, the aorta was removed
from the aortic arch to the iliac bifurcation using aseptic technique. Gross adventitial
attachments were removed and the aorta was opened longitudinally with iris scissors. The
adventitia was peeled from the ablumenal surface with watchmakers forceps, and both
the lumenal and ablumenal surfaces were scraped with a scalpel blade to remove endothe-
lial cells and remaining fibroblasts, respectively. Comparison of histological sections from
gross vs. cleaned aorta indicated that both old and young aortas were reduced to aortic
media as clearly defined by the presence of internal and external elastic laminae. The
vessels were then washed with HBS, minced, and the fragments placed into 10 ml of
Medium 199 plus 0.2% collagenase (CooperBiomedical, Inc., Malvern, PA) and 0.1
elastase (type 111; Sigma Chemical Co., St. Louis, MO). The aortic tissue was digested at
37°C with continuousagitation, and the enzyme mixture was changed at hourly intervals
until the tissue was completely dispersed. The enzymes were inactivated in the digestion
medium immediately after removal from incubation by adding equal parts offresh medium
containing 20% FCS. All enzyme-containing digests were pooled and filtered through a
30-,m nylon mesh; cells were pelleted by centrifugation; and ^-50,000 cells were plated
in growth medium per 25-cm' tissue culture flask. SMCs from old and young rat aortas,
harvested on the same day and cultured identically, were used as matched cultures in all
experiments. The cells exhibited a classic SMC phenotype and were studied during the
third to sixth passage.
Cell Culture Conditions. SMC were routinely maintained in medium consisting of
RPMI 1640 and Medium 199 (1 :1) containing 0.025 M Hepes, 20 MM L-glutamine, 50
,ug/ml gentamycin, and 10% FCS. Cells were grown to confluence and subpassaged by
treatment with trypsin-EDTA. Cultures were maintained in 75-cm' plastic culture flasks
(Corning GlassWorks, Corning, NY) in a water-saturated 5% C02-95% air atmosphere.
Proliferation Assay.
￿
To determine the time course of serum-induced proliferation, old
and young SMCs were plated at equal density (20,000/well) on microtiter plates and
growth arrested for 5 d in 2% PDS. Before stimulation by serum, five wells per age group
were used for cell counts to confirm equal plating. After the replacement of the medium
with fresh 2% PDS, FCS was added to groups of wells at a final concentration of 10% for
0-48 h before harvest. 1 h before harvest, [sH]TdR was added to a final concentration
of 1 uCi/ml and incubated at 37 ° C for 1 h . The cell layers were then washed, cells were
detached with trypsin, and the DNA was recovered onto fiberglass filter paper using an
automated cell harvester (Skatron Inc., Sterling, VA). The filter discs were placed in
borosilicate glass vials containing 6 ml of liquid scintillation fluid, Aquasol (DuPont Co.,
Wilmington, DE). Radioactivity of the filter discs was measured by liquid scintillation
counting. Replicates (n = 5) were averaged and expressed as a percent change above the
lowest [sH]TdR incorporation in each experiment.
Continuous Label.
￿
To determine the total number of cells entering the S-phase of the
cell cycle during the observation period, old and young SMCs were plated in 8-well slideMcCAFFREY ET AL.
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chambers (Labtek; Miles Laboratories Inc ., Naperville, IL), growth arrested, and stimu-
lated at the appropriate times by addition of 10% FCS plus 0.1 tiCi/ml [sH]TdR. At
harvest, the SMCs were washed, fixed with 4% paraformaldehyde, washed twice with cold
10% TCA, and autoradiographically exposed. Cells were scored manually at a magnifi-
cation of 1,250 . Data were expressed as the percent of labeled cells.
PDGF Dose-Response Protocol.
￿
Matched cultures of old and young SMCs were plated
at 20,000 cells/well side by side on microtiter plates in medium containing 2% PDS and
growth arrested for 5 d. The cells were then changed to fresh medium containing 2%
PDS and increasing doses of PDGF. 18 h later, ['H]TdR was added as 20 wl/well (final
concentration 1 tiCi/ml) for 4 h after which the DNA was harvested as described above.
The data from three assays were pooled after being normalized by expressing the dpm's
as a percent of the maximal incorporation (100%) recorded in each assay.
Serumfree Proliferation ofSMC.
￿
Cultures of old and young SMCs were harvested with
trypsin, counted, and plated onto 96-well microtiter plates in serum-free media (Hl-1)
supplemented only with 1.-glutamine and antibiotics. After 24 h (day 0), 5 wells of old and
young SMCs were harvested to confirm the similarityof plating densities. Cells were refed
every 4 d and on days 1, 7, and 14 were harvested with trypsin and counted in an
electronic cell counter (model ZBI ; Coulter Electronics Inc., Hialeah, FL). Data were
expressed as the mean ± SEM (n = 5).
Mitogenic/Inhibitory Activity of SMC Lysates.
￿
Old and young SMCs plated at equal cell
densities between 0.5 and 2.0 X 106 cells/75 cm' were cultured in serum-free medium
and then were harvested by scraping in HBS containing 0.02% EDTA. The cells were
collected by centrifugation, washed, and resuspended in 1 ml HBS per flask, and lysed by
rapid freeze-thawing three times. Cellular debris was removed by centrifugation at 10,000
g for 20 min and the cleared lysates were adjusted to equal protein concentrations (6) for
old and young SMC lysates prepared at each cell density. Bovine aortic smooth muscle
cells(BASMCs) were used as target cells to assay mitogenic activity of cell lysates. BASMCs
at 20,000 cells/microtiter well were partially growth arrested in medium containing 2%
PDS for 3 d. The test lysate (typically 20 Ag protein in 20 ;,l) was diluted with medium to
100 A1 and then mixed with an equal volume of medium containing 4% PDS, 100 wg/ml
gentamycin, and [sH]TdR (2 ,Ci/ml). BASMCs (n = 6 wells per group) were incubated
in this mixture for 24 h, washed, and the cells harvested. DNA-associated radioactivity
was determined as described above.
The negative control consisted of SMCs maintained in medium with 2% PDS only and
the positive control consisted of SMCs maintained in medium with 2% PDS and 4 U/ml
PDGF. To minimize interassay variation, the incorporation of ['H]TdR by the negative
controls (0%) was subtracted from all values and the remainder was expressed as a percent
of the ['H]TdR incorporation by SMCs stimulated with PDGF (100%). The presence of
PDGF-like molecules in the lysates was examined by the ability of PDGF antibodies to
reduce the mitogenic activity of the lysate. The antibody (1 :200 dilution of 3 mg/ml
rabbit IgG) was preincubated with the test agent (lysate or PDGF) 15 min before
application to the BASMCs. This particular antibody (anti-PDGF) is known to be PDGF
specific while demonstrating wide cross-species reactivity, including rat cellular PDGF.
Inhibition of SMC Proliferation by Heparin.
￿
The antiproliferative effects of sodium
heparin were assessed by two methods. First, serum-stimulated (5% NCS) SMC prolifer-
ation was measured after nine d of growth with refeeding at 3-d intervals. Heparin was
added to the medium from stock solutions to achieve final concentrations of 1, 10, or 100
jug/ml. At the end of the 9 d in medium with or without heparin, the cells were washed,
detached with trypsin, and counted in an electronic cell counter as described. Second,
['H]TdR incorporation was measured in a protocol identical to the PDGF dose-response
protocol except that concurrentwith addition of PDGF (4 U/ml) or control buffer, sodium
heparin (10 ALg/ml) was added to the wells. Incorporation of ['H]TdR into DNA by old
and young SMC incorporation was adjusted to dpm per cell.
Statistical Methods.
￿
Data were compared by analysis of variance (ANOV) for old vs.
young with repeated measures on the time factor, dose factor, or on cell density. For
continuous-label autoradiography, data were examined by the chi-square test. For serum-166
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Influence of age on the time course of incorporation of ['H]TdR incorporation
into DNA of confluent, cultured aortic SMCs stimulated by exposure to 10% FCS. Values for
old expressedas apercent of those for young cells at times specified following stimulation of
quiescent cultures by serum. (Inset) (Q) SMC from old (>19 mo) rats; (10 SMC from young
(<3 mo) rats. Data expressedas increase above baseline activity, mean ± SEM. Compositedata
from eight experiments with n = 6 per group within each experiment.
free proliferation and heparin-inhibition studies, a paired t test or ANOV with repeated
measures on dose of heparin was used. Differences were considered statistically significant
ifp < 0.05.
Effect ofDonor Age on the Time Course ofSerum-stimulated Thymidine Incorporation
in Arterial SMC Cultures. Equal numbers ofSMCs from old (mean ± SEM/well:
23,345 f 5,906) and young (23,874 ± 5,062) rataortas were placed into culture.
The [3H]TdR incorporation into DNA during a 1-h pulse was measured at 0, 6,
12, 18, 24, and 30 h after initiating stimulation with 10% FCS. Both old and
young SMCsincreased ['H]TdR incorporation during the first 24 hafter addition
of serum (Fig. 1, inset). However, over the first 18 h after serum stimulation, old
SMCs incorporated ['H]TdR at a significantly higher average rate (638.9
dpm/well per h) than comparable numbers ofyoung SMCs (309.5 dpm/well per
h; p = 0.005, ANOV). SMCs from old aortas incorporated twice as much [3H]-
TdR as SMCs from young aortas at baseline and this difference increased to
nearly threefold at 12 h (Fig. 1). However, by 24 h the ['H]TdR incorporation
rates for the two groups were statistically comparable (F = 0.06, p > 0.05,
ANOV). This increase in DNA synthesis was followed by cell proliferation, with
cell numbers increasing for both old (2.8-fold) and young (2.5-fold) SMCs by 48
h of serum stimulation.
To rule out possible artefacts such as differences in nucleotide pool sizes that
might affect ['H]TdR incorporation, the cumulative numbers ofcells in the totalMcCAFFREY ET AL.
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TABLE I
Entry into Cell Cycle S-phase by Cultured SMC Isolatedfrom Young
and Old Rats
SMCs from young and old rats were cultured in slide chambers in the
absence or presence of 10% FCS for the times specified. ['HITDR was
added to the cultures concurrently with the FCS. At the timesspecified,
the cells were fixed with paraformaldehyde and prepared for autora-
diographyas describedin MaterialsandMethods. Cells with >20 grains/
nucleus were considered to have entered the S-phase of the cell cycle.
The data presented are the means of two comparable experiments
assessing >125 cells/point in duplicate.
* Significantly different from young:p < 0.05.
old or young SMC population that entered the S-phase of the cell cycle after
serum stimulation was determined autoradiographically by continuous [sH]TdR
labeling over the same time period (Table 1). During the first 18 h after serum
stimulation, a greater percentage of old SMCs enter S-phase of the cell cycle
than young SMCs similarly treated. By 30 h in the presence of serum, as had
been seen in the pulse-label studies, there was no significant difference between
old and young SMCs, as nearly all cells in both populations had entered the S-
phase ofthe cell cycle. Incontrast, after 30 h in the absenceofserum, significantly
more old than young cells had entered the proliferative cycle. Thus, the critical
age-related differences are most prominent in the absence of serum or in the
initial responses to proliferative stimuli.
The Effect of Donor Age on PDGF-stimulated ['H]TdR Incorporation.
￿
Because
the predominant serum mitogen for SMCs is PDGF, we investigated whether
old SMCs were more responsive to PDGF than young SMCs. Consistent with the
previous studies, quiescent, confluent old SMCs maintained in medium plus 2%
PDS incorporated twofold more [3H]TdR than young SMCs. When increasing
doses of PDGF were added to cultures maintained in 2% PDS, both old and
young SMCs increased [sH]TdR incorporation in a dose dependent manner (F
= 35.5, p < 0.001) (Fig. 2). The maximal response ofold SMCswas greater than
that ofyoung SMCs and occurred at a lower dose of PDGF (2 U/ml). Old SMCs
incorporated more [sH]TdR than young SMCs at all doses of PDGF tested (F =
33.1, p < 0.001). However, because young SMC had lower baseline [sH]TdR
uptake, they showed a greater relative increase in the presence of PDGF. The
high baseline activity observed with the old SMCs in the absence ofadded PDGF
is a consistent characteristic of the aged SMCs thatwas examined in the following
experiment.
Culture period (h)
Percent
Old
labeled cells
Young
With serum
6 32.8* 13.8
12 51 .1 44.2
18 88.2* 71 .9
24 93.8 89.9
30 96.8 96.3
No serum (control)
30 65.0* 46.0168
z
0
a
J
N
J a
a
E
0
0 0
75-4
'-' 50 -~
¢ w m
z
J
w 25-
0
AGING AND SMOOTH MUSCLE CELL PROLIFERATION
PDGF (U/ml)
FIGURE 2 .
￿
The proliferative re-
sponse of old and young SMCs
to increasing concentrations of
PDGF. Symbolsas in Fig. 1. [sH]-
TdR incorporation 22 h afterad-
dition of human PDGF and 4 h
after addition of isotope to
growth-arrested cultures of SMC
in medium containing 2% PDS.
Results expressedas mean ±SEM
percent of maximal dpm's ob-
served in each of three experi-
ments.
FIGURE 3 .
￿
The effects of age on SMC proliferation in serum-free medium. Old and young
SMCs were plated in serum-free HL-I medium on day 1. Cell counts were made at days 0, 1,
7, and 14. Symbols as in Fig. 1. Representative experiment with n = 5 wellsper group.
Serumfree Proliferation of Rat Aortic SMCs.
￿
Increased mitotic activity of old
SMCs in the absence of serum and under low-serum conditions, combined with
their pattern of responses to stimulation by serum and PDGF, suggested the
possibility that old SMCs may be capable of autocrine production of growth
factors. We examined the ability of SMCs from old and young rats to proliferate
in serum-free medium (HL-1) that contained cell-cycle progression factors (i.e.,
insulin, transferrin), but no detectable competence factors. Fig. 3 demonstrates
that the number of old SMCs after 14 d of culture in serum-free medium was
significantly greater than the number of young SMCs (t(8) = 6.5, p < 0 .001)
even though the initial plating density of the young SMCs was slightly higher.
Mitogenic Effects of Cell Lysates from Old and Young Rat SMC.
￿
The ability of
the old SMCs to proliferate in the absence of exogenous growth factors suggested
that they may be capable of producing and using their own growth factors,z
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FIGURE 4 .
￿
Influence of lysates of young and old aortic SMCs on proliferative responses of
target cells (BASMCs) . Effects of age and of cell density of cultures used to prepare lysate.
(Ordinate) Percent stimulation indicates lysate-stimulated thymidine incorporation compared
to 2% PDS control (Con, 0%)and to 4 U/ml PDGF (100%) . Data as mean t SEM, duplicate
experiments on separate cell lines, n = 6perexperiment . (Open bar)PDGF control ; (solid bars)
old SMCs ; (slashed bars) young SMCs ; " indicates p< 0.05 .
particularly PDGF . Thus, we examined the capacity of cell-associated materials
prepared from old and young SMCs to influence the proliferation of quiescent
target BASMCs . Freeze-thaw lysates were prepared from old and young SMCs
cultured in serum-free media . Lysates containing equal amounts of protein
stimulated or inhibited [sH]TdR incorporation intoDNA ofBASMCs depending
upon two factors : the cell density of the rat SMC culture used to prepare the
lysates, and the age of the rats from which the SMC were isolated (Fig. 4) . The
amount of lysate loaded was chosen from pilot dose-response studies to provide
a subsaturating stimulation of [sH]TdR incorporation . In general, lysates pre-
pared from preconfluent cultures (0 .5 X 106 cells/75 cm2) stimulated prolifera-
tion, and lysates prepared from confluent cultures (2 X 106 cells/75 cm2) were
inhibitory when tested in this assay (ANOV, F = 38, p < 0.001) . Lysates from
old SMCs grown at 0.5 and 1 .0 X 106 cells/75 cm2 flask were significantly more
stimulatory than lysates from young SMCs (F = 23.6, p < 0.001) . Likewise, old
SMCs from confluent cultures (2.0 X 106 cells/flask) were less inhibitory than
were similar lysates from young SMC cultures containing the same protein
concentration . When preconditioned media from similarly treated cultures were
examined for growth factor activity, we observed that, though more variable
with respect to overall stimulatory activity, the preconditioned media rendered
results qualitatively similar to those presented in Fig. 4 . Thus, old SMCs con-
tained either greater amounts of growth stimulators or lower amounts of growth
inhibitors than young SMCs .170
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￿
Effects of antibody to PDGF on proliferative responses of target BASMCs to
lysates of aortic SMCs from old or young rats. Effects of lysates from sparse (0.5 X 106
cells/flask) or confluent (2.0 X 106 cells/flask) rat aortic SMC cultures are compared with
PDGF. (A) Proliferative effects oflysatesin the absence ofanti-PDGF. (B) Proliferative effects
of lysates after theirtreatment with anti-PDGF. Ordinate andsymbolsas in Fig. 4.
The contribution of PDGF-like molecules to the mitogenic activity observed
was evaluated by incubating the lysates with antibody to PDGF before adding
them to target cells. The anti-PDGF antibody completely blocked the stimulatory
effect of purified PDGF in the BASMC assay (Fig. 5). Nonimmune rabbit IgG at
a similar dilution (1 :200) had no effect on the activity of purified PDGF: PDGF-
stimulated activity = 1,840 ± 184 dpm (mean ± SEM), plus nonimmune IgG =
1,790 ± 156 dpm (p > 0 .05). Addition of anti-PDGF to the lysates eliminated
their stimulatory effect on [sH]TdR incorporation (F = 64.8, p < 0.001) and
revealed different degrees of inhibition by lysates from old and young SMC.
Antibody-treated lysates from old SMCs had less inhibitory activity at high cell
density than lysates from young SMCs (t(10) = 2.3, p < 0 .05). This suggests that
PDGF-like activity accounts for some of the growth-stimulating activity in the
lysates, but raises the possibility that old and young SMCs may differ in the levels
of growth-inhibiting agents.
Effects of Growth Inhibitors on Proliferation of Old and Young SMCs.
￿
The
importance of differences in growth inhibitors on the proliferative capacity of
SMCs from old and young rat aortas is suggested by studies with heparin, a
major inhibitor of SMC growth . In the absence of heparin, serum-stimulated old
SMCs proliferated significantly better than young SMCs (Fig. 6, t(8) = 4.4, p =
0.002) as we have shown earlier. However, addition of heparin to the cultures
not only reduced SMC proliferation in a dose-dependent fashion (F = 23 .6, p <
0.001) in all SMC cultures but also abolished the proliferative advantage of the
old SMCs (F = 0 .089, p > 0.1).
The effect of heparin on proliferation under nonstimulated or PDGF-stimu-
lated conditions, two other areas in which old and young SMCs differ, corrobo-
rated the difference in sensitivity of old and young cells to growth inhibition.F
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FIGURE 7. Effects of hepa-
rin on PDGF-stimulated and
unstimulated incorporation of
['H]TdR. Activity determined
(dpm/cell) during a 4-h incu-
bation, 18 h afterexposure to
heparin (10 ug/ml). Data as
mean f SEM; representative
experiment, n = 5; " indicates
p <0.05.
Using a short-term [3H]TdR incorporation assay, we observed that heparin (10
,ug/ml) abolished both the significantly elevated baseline (t = 4.9, p = 0.001) and
PDGF-stimulated [3H]TdR incorporation by old SMCs (t = 10.5, p < 0.001)
(Fig. 7). Thus, in the presence of heparin, proliferative responses of old and
young SMCs become comparable.
Discussion
invasion of the intima by medial smooth muscle cells and their proliferation
within the arterial wall represent key pathological steps in arteriosclerosis. Aging
appears to augment the development of sustained arteriosclerotic lesions in
animal models and may be related to this process in humans. We have previously
reported that the increased susceptibility of the aorta of old animals to arterio-
sclerosis is an intrinsic property of the vessel and not ofthe host (4). The studies
reported here demonstrate the increased proliferation in tissue culture of aortic
SMCs isolated from old rats as compared to those of young rats grown under172
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identical conditions. Thus, the exaggerated SMC proliferation observed after
vascular injury ofagedanimals in vivo isparalleled by the in vitro growth pattern
of SMCs derived from uninjured vessels. This finding is consistent with our
hypothesis that the increasing risk of arteriosclerosis with age reflects a dysreg-
ulation ofcell growth and differentiation during the aging process.
The augmented proliferative response ofSMCs from old animals is character-
ized by three pertinent attributes. First, SMCs from old animals incorporate
more [3H]TdR into DNA under serum-free baseline conditions after growth
arrest than do SMCs from young animals. Second, quiescent old SMCs respond
more rapidly when exposed to progression factors and incorporate more [sH]-
TdR into DNA after exposure to serum than young SMCs, suggesting that some
old SMCs "rest" in an early G, stage ofthe cell cycle, requiring only progression
factors to enter mitosis. Third, old SMCs reach maximal levels of [sH]TdR
incorporation at lower concentrations of exogenous PDGF than young SMCs.
Indeed, equivalent levels of incorporation could not be achieved in the young
SMCs at testable concentrations of PDGF. These observations imply that more
SMCs from old animals remain in cell cycle under conditions that inhibit
proliferation ofyoung SMCs, and therefore old SMCs respond more rapidly and
more vigorously to introduction of progression factors. These conclusions are
based not only on data from thymidine incorporation, which may be influenced
by intracellular thymidine pool size or by polyploidy, but also on increased cell
counts of cultures of old and young SMCs after exposure to serum or PDGF.
Both flow cytometric analysis (Hariri, R.J., D. P. Hajjar, D. Coletti, D. R. Alonso,
andE. Rabellino, submitted forpublication) andautoradiographyofcontinuously
[sH]TdR-labeled cells also reveal an increased number ofold SMCs in S-phase
before and soon after serum stimulation.
This evidence suggested to us that growth of aortic SMCs was altered in
relation to age. We investigated whether more growth factor activity might be
associated with old compared to young SMCs. Several studies of rat arterial
SMCs have demonstrated the presence of PDGF-like proteins (7-9) or the
expression of genes coding for the A-chain (10) and, in injured SMCs (11) the
B-chain (c-sis) of a PDGF-like protein. We predicted that old SMCs may have
higher levels of a cellular PDGF that rendered them partially independent of
exogenous growth factors. This hypothesis was supported by the fact that lysates
prepared from old SMCs stimulated the proliferation of target BASMCs more
than did lysates from young SMCs and that the mitogenic activity was completely
blocked byspecific antibody to PDGF. Blockade of PDGF-like activity by specific
antibody further exposed the inhibitory action of the cell-associated inhibitors
and demonstrated that lysates of confluent old SMCs are less inhibitory than
lysates ofyoung SMCs.
Arterial SMCs grown in vitro are known to produce heparan sulfates that
increase in growth-inhibiting activity as the cells reach confluence (12). Since
these heparin-like molecules appear to be important in maintaining quiescence
of confluent SMCs in vitro or in situ, we compared the effects of exogenous
heparin on thegrowth ofold and young SMCs. Proliferation ofserum-stimulated
old SMCs was particularly sensitive to inhibition by heparin. This inhibition of
old SMC proliferation was also observed under serum-deprived conditions inMcCAFFREY ET AL.
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which old, but not young, SMCs grow. Together with our findingthat old SMCs
produce less growth-inhibiting activity (presumably heparins) than young SMCs
andare more easily blocked from proliferation by exogenous heparin, these data
suggest thata deficitin the amount and/or inhibitory efficacy ofcellular heparins
at confluence contributes to the enhanced proliferative activity of old aortic
SMCs. Thus, it is possible that heparin might mitigate the excessive proliferative
response of the aged vessel to injurious conditions in vivo. It is known that
intimal hyperplasia in rats (12) and rabbits (13) afterexperimental vascular injury
is inhibited by heparin. Characterization of the rate of production of growth-
inhibiting heparin-like glycosaminoglycans by old and young vascular SMCs will
help todetermineifdefectsin production or in theprocessing ofcellular heparins
accounts for the age-related proliferative differences we have observed.
We conclude that age-related changes in aortic plaque formation after injury
in vivo involve changes in the behavior of the vascular SMCs. The in vivo
proliferative response parallels intrinsic, age-related differences in the prolifera-
tive behavior of isolated aortic SMCs in vitro. These studies emphasize that the
mechanism underlying the differences in proliferation of old and young aortic
SMCs involves at least two interacting processes: an increased cellular PDGF-
relatedactivity by oldSMCs, and a concomitantdecrease in cell-associated growth
inhibitors.
Summary
In vivo studies have suggested that the aorta from an old animal responds to
injury with an exaggerated proliferation ofsmooth muscle cells (SMCs) compared
with the response of this aorta from a young animal . In this study we compared
proliferation ofSMCs derived from uninjured old (<19 mo) and young (3-4 mo)
rat aortas. Old SMCs grew more rapidly than young SMCs in the presence of
medium containing competence factors (10% FCS or platelet-derived growth
factor [PDGF]) as well as in their absence (2% PDS or serum-free media) as
determined both by a short-term thymidine incorporation assay and by cell
counts . Lysates prepared from old SMCs that had been grown in the absence of
serum or PDGF stimulated proliferation of target cells more than lysates pre-
pared from young SMCs; the effect was inversely related to cell density of the
SMCs. This stimulatory effect of lysates was completely blocked by antibody to
PDGF. After the growth-promoting activity of lysates was eliminated by anti-
PDGF, growth-inhibiting activity was revealed. Lysates prepared from old SMCs
had significantly less capacity to inhibit target cell growth. In the presence of
exogenousheparin both theserum- orPDGF-stimulated proliferation and serum-
free proliferation of old SMCs were decreased to the level of proliferation of
young SMCs. These results suggest that the balance between growth-promoting
and growth-inhibiting factors is altered in SMCs from old rats. This may contrib-
ute to the increased proliferative capacity of these cells in culture and may
facilitate the development ofatherosclerosis with age.
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